Canada has become one of the first major markets where lower-cost generic versions of the blockbuster diabetes and weight-loss drug…
Read MoreCanada has become one of the first major markets where lower-cost generic versions of the blockbuster diabetes and weight-loss drug…
Read MoreSudhir Choudhary | March 20, 2026 Affordable Alternatives Emerge From India’s Pharmaceutical Sector India’s rapidly expanding pharmaceutical industry is positioning…
Read MoreCheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countriesWeight-loss jabs such…
Read More